EURORDIS welcomes the Commission’s ‘promising’ Biotech Act I December 2025

EURORDIS welcomes the Commission’s ‘promising’ Biotech Act I December 2025 16 December 2025, Strasbourg – While EURORDIS–Rare Diseases Europe will take more time to analyse the European Commission’s Biotech Act I proposals in detail, we welcome this important step towards strengthening Europe’s capacity to innovate in health and translate scientific progress into tangible benefits for society. https://www.eurordis.org/eurordis-welcomes-commissions-biotech-act-i/